Ulcerative Colitis: The Complete Guide to Medical Management

頁數：488　裝訂：精裝 　開數：28.7*22.3 　印刷：黑白　重量：1.85KG

Product Description
Ulcerative Colitis: The Complete Guide to Medical Management serves as the definitive source for medical management of ulcerative colitis (UC).

Dr. Gary R. Lichtenstein, along with Dr. Ellen J. Scherl, have collaborated with over 60 experts from around the world to provide gastroenterologists and those in training with the necessary information to successfully manage the patient with ulcerative colitis.

Sections Include:
General
The role of the FDA in drug development; pediatric considerations; disease modifiers; and more
Medications
Antibiotic use in treatment of UC; oral novel biological therapies for UC; calcineurin inhibitors use in UC; novel biologic and non-biologic therapy for UC; and more
Specific Clinical Presentations
Medical management of toxic megacolon; management of extraintestinal manifestations; medical therapy of left-sided UC; use of prebiotics and probiotics; maintenance of remission; and more

Features:
--Color images, graphs, and tables
--Extensive index that includes cross-referencing to Crohn’s Disease: The Complete Guide to Medical Management
--Comprehensive references at the end of each chapter

Organized into an easy-to-reference format, Ulcerative Colitis: The Complete Guide to Medical Management threads theory into practice and provides gastroenterology professionals with the most comprehensive information available.

The other side of inflammatory bowel disease is covered in Drs. Gary R. Lichtenstein and Ellen J. Scherl’s Crohn’s Disease: The Complete Guide to Medical Management. All gastroenterologists will find both books to be essential for future practice in the treatment and care of their patients with either Crohn’s disease or ulcerative colitis, as well as in the overall management of those with inflammatory bowel disease.

Contents
Section I: General

Chapter 1: The Natural History of Inflammatory Bowel Disease

Pietro G. Andres, MD and Lawrence S. Friedman, MD

Chapter 2: Clinical Research in Inflammatory Bowel Disease: Placebo Response in Clinical Trials

Chinyu Su, MD and James D. Lewis, MD, MSCE

Chapter 3: The Role of the FDA in Drug Development in Inflammatory Bowel Disease

Alan C. Moss, MD, FACG and Adam S. Cheifetz, MD

Chapter 4: Utility of Animal Models for the Study and Treatment of Inflammatory Bowel Disease

Ashish Chawla, MD and Kenneth Simpson, BVM&S, PhD

Chapter 5: Pediatric Considerations in Medical Therapy in Patients With Inflammatory Bowel Disease

Louis R. Ghanem, MD, PhD and Robert N. Baldassano, MD

Chapter 6: The Limitations of Applying Evidence-Based Medicine to Inflammatory Bowel Disease: What We Do Not Learn From Clinical Trials

Joshua R. Korzenik, MD and Corey A. Siegel, MD

Chapter 7: Disease Modifiers in Inflammatory Bowel Disease

Jaime A. Oviedo, MD and Francis A. Farraye, MD, MSc, FACP, FACG

Chapter 8: Fertility and Pregnancy in Inflammatory Bowel Disease

Jeffry A. Katz, MD and Vinita Elizabeth Jacob, MD

Chapter 9: Diversion Colitis

Eugeni Domènech, MD, PhD and Miguel A. Gassull, MD, PhD

Chapter 10: Medication Adherence in Inflammatory Bowel Disease

Sunanda V. Kane, MD, MSPH, FACG, FACP, AGAF

Section II: Medications

Chapter 11: General Principles of Medical Therapy of Ulcerative Colitis

Sonia Friedman, MD, FACP

Chapter 12: Assessment of Disease Activity in Ulcerative Colitis

Anthony L. Rosa, MD and Thomas A. Judge, MD

Chapter 13: Current and Future Oral Mesalamine Derivative Use in Ulcerative Colitis

Lloyd Sutherland, MDCM, MSc, FRCP(C), FACP

Chapter 14: Current and Future Topical Mesalamine Derivatives in Ulcerative Colitis

Jeffrey W. Nathanson, MD and Russell D. Cohen, MD

Chapter 15: Antibiotics in Ulcerative Colitis

Kim L. Isaacs, MD, PhD

Chapter 16: Oral and Parenteral Corticosteroids in Ulcerative Colitis

Leonard Baidoo, MD and Gary R. Lichtenstein, MD, FACP, FACG, AGAF

Chapter 17: Topical Corticosteroid Use in Ulcerative Colitis

Seymour Katz, MD, FACP, MACG

Chapter 18: 6-Mercaptopurine and Azathioprine Use in Ulcerative Colitis

Marla C. Dubinsky, MD

Chapter 19: Azathioprine Metabolism in Inflammatory Bowel Disease: A Physician’s Guide to Metabolite Testing

Carmen Cuffari, MD

Chapter 20: Methotrexate in the Treatment of Ulcerative Colitis

Ellen J. Scherl, MD, FACP, AGAF; Vinita Elizabeth Jacob, MD; Brian P. Bosworth, MD; Ryan Urquhart Warren, MD; and Harrison Lakehomer, BA

Chapter 21: Calcineurin Inhibitors (Cyclosporine, Tacrolimus, Sirolimus) and Mycophenolate Motefil Use in Ulcerative Colitis

Hans Herfarth, MD, PhD and Jürgen Schölmerich, MD, PhD

Chapter 22: Infliximab Use in Ulcerative Colitis

Wojciech Blonski, MD, PhD; Antoni Stadnicki, MD, PhD; Gary R. Lichtenstein, MD, FACP, FACG, AGAF; and Anne Burke, MD

Chapter 23: Other Tumor Necrosis Factor-Alpha Antagonists in Ulcerative Colitis

Joshua R. Korzenik, MD

Chapter 24: Novel Biological Agents for the Treatment of Ulcerative Colitis

Gert Van Assche, MD, PhD, FRCP and Paul Rutgeerts, MD, PhD, FRCP

Chapter 25: Novel Nonbiologic Therapy for Ulcerative Colitis

William J. Sandborn, MD

Section III: Specific Clinical Presentations

Chapter 26: Medical Management of Severe Ulcerative Colitis

Niraj Jani, MD and Miguel Regueiro, MD

Chapter 27: Medical Management of Toxic Megacolon in the Patient with Ulcerative Colitis

Robynne Chutkan, MD and Nabil Toubia, MD

Chapter 28: Medical Management of Ulcerative Proctitis

Philip B. Miner Jr, MD

Chapter 29: Medical Therapy of Left-Sided Ulcerative Colitis

Douglas B. Haghighi, DMD, MD and Bret A. Lashner, MD, MPH

Chapter 30: Management of Refractory Ulcerative Colitis

Edward V. Loftus Jr, MD; Ellen J. Scherl, MD, FACP, AGAF; and Melissa H. Rosen, MD

Chapter 31: Pseudointractability of Inflammatory Bowel Disease

Mansour A. Parsi, MD and Jean-Paul Achkar, MD

Chapter 32: Medical Management of Extraintestinal Manifestations of Ulcerative Colitis

Lloyd Mayer, MD and Robert Pittman, MD

Chapter 33: Nicotine and Inflammatory Bowel Disease

Truc T. Trinh, MD; Richard S. Bloomfeld, MD, MS; and Stephen J. Bickston, MD, AGAF

Chapter 34: Management of Steroid-Refractory and Steroid-Dependent Severe Ulcerative Colitis

Jesse A. Green, MD, FACG and Richard P. MacDermott, MD, FACG

Chapter 35: Prebiotics and Probiotics in Ulcerative Colitis

Robert M. Penner, BSc, MD, FRCP(C), MSc; Karen L. Madsen, PhD; Massimo Campieri, MD; and Richard N. Fedorak, MD, FRCP(C)

Chapter 36: Management of Acute and Chronic Pouchitis

James M. Becker, MD, FACS and Arthur F. Stucchi, PhD

Chapter 37: Dietary Manipulations: Oral and Enteral Nutritional Therapy for Ulcerative Colitis

Traci M. Temmen, MD and John L. Rombeau, MD

Chapter 38: Parenteral Nutrition Use in Ulcerative Colitis

Alan L. Buchman, MD, MSPH

Chapter 39: Maintenance of Remission in Ulcerative Colitis

Kenneth W. Schroeder, MD, PhD and William J. Tremaine, MD

Financial Disclosures
Index